The Transcription Factors Egr2 and Egr3 Are Essential for the Control of Inflammation and Antigen-Induced Proliferation of B and T Cells

Immunity

Volumn 37, Issue 4, 2012, Pages 685-696

  Li, Suling ^a   Miao, Tizong ^b   Sebastian, Meera ^b   Bhullar, Punamdip ^a   Ghaffari, Emma ^a   Liu, Mengya ^a   Symonds, Alistair L J ^b   Wang, Ping ^b  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; INTERLEUKIN 2; LYMPHOCYTE ANTIGEN RECEPTOR; STAT1 PROTEIN; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR AP 1;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DNA BINDING; HOMEOSTASIS; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CELL PROLIFERATION; EARLY GROWTH RESPONSE PROTEIN 2; EARLY GROWTH RESPONSE PROTEIN 3; HOMEOSTASIS; INFLAMMATION; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTOR AP-1;

EID: 84867876944     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.08.001     Document Type: Article

References (51)

1. Anderson P., Sundstedt A., Li L., O'Neill E.J., Li S., Wraith D.C., Wang P. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells. Int. Immunol. 2003, 15:1309-1317.
2. Anderson P.O., Manzo B.A., Sundstedt A., Minaee S., Symonds A., Khalid S., Rodriguez-Cabezas M.E., Nicolson K., Li S., Wraith D.C., Wang P. Persistent antigenic stimulation alters the transcription program in T cells, resulting in antigen-specific tolerance. Eur. J. Immunol. 2006, 36:1374-1385.
3. Bandyopadhyay S., Duré M., Paroder M., Soto-Nieves N., Puga I., Macián F. Interleukin 2 gene transcription is regulated by Ikaros-induced changes in histone acetylation in anergic T cells. Blood 2007, 109:2878-2886.
4. Betz B.C., Jordan-Williams K.L., Wang C., Kang S.G., Liao J., Logan M.R., Kim C.H., Taparowsky E.J. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 2010, 207:933-942.
5. Chen Z., Laurence A., Kanno Y., Pacher-Zavisin M., Zhu B.M., Tato C., Yoshimura A., Hennighausen L., O'Shea J.J. Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc. Natl. Acad. Sci. USA 2006, 103:8137-8142.
6. Chong M.M., Metcalf D., Jamieson E., Alexander W.S., Kay T.W. Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. Blood 2005, 106:1668-1675.
7. Crispín J.C., Apostolidis S.A., Finnell M.I., Tsokos G.C. Induction of PP2A Bβ, a regulator of IL-2 deprivation-induced T-cell apoptosis, is deficient in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 2011, 108:12443-12448.
8. Croker B.A., Metcalf D., Robb L., Wei W., Mifsud S., DiRago L., Cluse L.A., Sutherland K.D., Hartley L., Williams E., et al. SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 2004, 20:153-165.
9. Davey G.M., Starr R., Cornish A.L., Burghardt J.T., Alexander W.S., Carbone F.R., Surh C.D., Heath W.R. SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J. Exp. Med. 2005, 202:1099-1108.
10. Diehl S., Anguita J., Hoffmeyer A., Zapton T., Ihle J.N., Fikrig E., Rincón M. Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 2000, 13:805-815.
11. Foletta V.C., Segal D.H., Cohen D.R. Transcriptional regulation in the immune system: all roads lead to AP-1. J. Leukoc. Biol. 1998, 63:139-152.
12. Goodnow C.C., Vinuesa C.G., Randall K.L., Mackay F., Brink R. Control systems and decision making for antibody production. Nat. Immunol. 2010, 11:681-688.
13. Guinea-Viniegra J., Zenz R., Scheuch H., Hnisz D., Holcmann M., Bakiri L., Schonthaler H.B., Sibilia M., Wagner E.F. TNFalpha shedding and epidermal inflammation are controlled by Jun proteins. Genes Dev. 2009, 23:2663-2674.
14. Harris J.E., Bishop K.D., Phillips N.E., Mordes J.P., Greiner D.L., Rossini A.A., Czech M.P. Early growth response gene-2, a zinc-finger transcription factor, is required for full induction of clonal anergy in CD4+ T cells. J. Immunol. 2004, 173:7331-7338.
15. Ise W., Kohyama M., Schraml B.U., Zhang T., Schwer B., Basu U., Alt F.W., Tang J., Oltz E.M., Murphy T.L., Murphy K.M. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells. Nat. Immunol. 2011, 12:536-543.
16. Jenks S.A., Sanz I. Altered B cell receptor signaling in human systemic lupus erythematosus. Autoimmun. Rev. 2009, 8:209-213.
17. King C.G., Buckler J.L., Kobayashi T., Hannah J.R., Bassett G., Kim T., Pearce E.L., Kim G.G., Turka L.A., Choi Y. Cutting edge: requirement for TRAF6 in the induction of T cell anergy. J. Immunol. 2008, 180:34-38.
18. Kitaura Y., Jang I.K., Wang Y., Han Y.C., Inazu T., Cadera E.J., Schlissel M., Hardy R.R., Gu H. Control of the B cell-intrinsic tolerance programs by ubiquitin ligases Cbl and Cbl-b. Immunity 2007, 26:567-578.
19. Lazarevic V., Zullo A.J., Schweitzer M.N., Staton T.L., Gallo E.M., Crabtree G.R., Glimcher L.H. The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells. Nat. Immunol. 2009, 10:306-313.
20. Li S., Symonds A.L., Zhu B., Liu M., Raymond M.V., Miao T., Wang P. Early growth response gene-2 (Egr2) regulates the development of B and T cells. PLoS ONE 2011, 14:e18498. 10.1371/journal.pone.0018498.
21. MacDonald T.T., Monteleone I., Fantini M.C., Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011, 140:1768-1775.
22. Macián F., López-Rodríguez C., Rao A. Partners in transcription: NFAT and AP-1. Oncogene 2001, 20:2476-2489.
23. Macián F., García-Cózar F., Im S.H., Horton H.F., Byrne M.C., Rao A. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 2002, 109:719-731.
24. Marine J.C., Topham D.J., McKay C., Wang D., Parganas E., Stravopodis D., Yoshimura A., Ihle J.N. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 1999, 98:609-616.
25. Meixner A., Zenz R., Schonthaler H.B., Kenner L., Scheuch H., Penninger J.M., Wagner E.F. Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat. Cell Biol. 2008, 10:1003-1011.
26. Miao T., Wu D., Zhang Y., Bo X., Subang M.C., Wang P., Richardson P.M. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J. Neurosci. 2006, 26:9512-9519.
27. Myouzen K., Kochi Y., Shimane K., Fujio K., Okamura T., Okada Y., Suzuki A., Atsumi T., Ito S., Takada K., et al. Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus. Hum. Mol. Genet. 2010, 19:2313-2320.
28. O'Donovan K.J., Tourtellotte W.G., Millbrandt J., Baraban J.M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 1999, 22:167-173.
29. Pflegerl P., Vesely P., Hantusch B., Schlederer M., Zenz R., Janig E., Steiner G., Meixner A., Petzelbauer P., Wolf P., et al. Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc. Natl. Acad. Sci. USA 2009, 106:20423-20428.
30. Pospisil V., Vargova K., Kokavec J., Rybarova J., Savvulidi F., Jonasova A., Necas E., Zavadil J., Laslo P., Stopka T. Epigenetic silencing of the oncogenic miR-17-92 cluster during PU.1-directed macrophage differentiation. EMBO J. 2011, 30:4450-4464.
31. Puga I., Rao A., Macian F. Targeted cleavage of signaling proteins by caspase 3 inhibits T cell receptor signaling in anergic T cells. Immunity 2008, 29:193-204.
32. Quigley M., Pereyra F., Nilsson B., Porichis F., Fonseca C., Eichbaum Q., Julg B., Jesneck J.L., Brosnahan K., Imam S., et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat. Med. 2010, 16:1147-1151.
33. Rauen T., Benedyk K., Juang Y.T., Kerkhoff C., Kyttaris V.C., Roth J., Tsokos G.C., Tenbrock K. A novel intronic CREM promoter is regulated by AP-1 and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus. J. Biol. Chem. 2011, 286:32366-32372.
34. Rincón M., Flavell R.A. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 1994, 13:4370-4381.
35. Safford M., Collins S., Lutz M.A., Allen A., Huang C.T., Kowalski J., Blackford A., Horton M.R., Drake C., Schwartz R.H., Powell J.D. Egr-2 and Egr-3 are negative regulators of T cell activation. Nat. Immunol. 2005, 6:472-480.
36. Schraml B.U., Hildner K., Ise W., Lee W.L., Smith W.A., Solomon B., Sahota G., Sim J., Mukasa R., Cemerski S., et al. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009, 460:405-409.
37. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 2003, 21:305-334.
38. Sela U., Dayan M., Hershkoviz R., Lider O., Mozes E. A peptide that ameliorates lupus up-regulates the diminished expression of early growth response factors 2 and 3. J. Immunol. 2008, 180:1584-1591.
39. Sprent J., Surh C.D. Normal T cell homeostasis: the conversion of naive cells into memory-phenotype cells. Nat. Immunol. 2011, 12:478-484.
40. Taleb S., Romain M., Ramkhelawon B., Uyttenhove C., Pasterkamp G., Herbin O., Esposito B., Perez N., Yasukawa H., Van Snick J., et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J. Exp. Med. 2009, 206:2067-2077.
41. Tamiya T., Kashiwagi I., Takahashi R., Yasukawa H., Yoshimura A. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler. Thromb. Vasc. Biol. 2011, 31:980-985.
42. Tanaka K., Ichiyama K., Hashimoto M., Yoshida H., Takimoto T., Takaesu G., Torisu T., Hanada T., Yasukawa H., Fukuyama S., et al. Loss of suppressor of cytokine signaling 1 in helper T cells leads to defective Th17 differentiation by enhancing antagonistic effects of IFN-gamma on STAT3 and Smads. J. Immunol. 2008, 180:3746-3756.
43. Thomas R.M., Chunder N., Chen C., Umetsu S.E., Winandy S., Wells A.D. Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes. J. Immunol. 2007, 179:7305-7315.
44. Topilko P., Schneider-Maunoury S., Levi G., Baron-Van Evercooren A., Chennoufi A.B., Seitanidou T., Babinet C., Charnay P. Krox-20 controls myelination in the peripheral nervous system. Nature 1994, 371:796-799.
45. Tourtellotte W.G., Milbrandt J. Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat. Genet. 1998, 20:87-91.
46. von Boehmer H., Melchers F. Checkpoints in lymphocyte development and autoimmune disease. Nat. Immunol. 2010, 11:14-20.
47. Williams K.L., Nanda I., Lyons G.E., Kuo C.T., Schmid M., Leiden J.M., Kaplan M.H., Taparowsky E.J. Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur. J. Immunol. 2001, 31:1620-1627.
48. Xi H., Schwartz R., Engel I., Murre C., Kersh G.J. Interplay between RORgammat, Egr3, and E proteins controls proliferation in response to pre-TCR signals. Immunity 2006, 24:813-826.
49. Zenz R., Eferl R., Kenner L., Florin L., Hummerich L., Mehic D., Scheuch H., Angel P., Tschachler E., Wagner E.F. Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005, 437:369-375.
50. Zhu J., Paul W.E. Heterogeneity and plasticity of T helper cells. Cell Res. 2010, 20:4-12.
51. Zhu B., Symonds A.L., Martin J.E., Kioussis D., Wraith D.C., Li S., Wang P. Early growth response gene 2 (Egr-2) controls the self-tolerance of T cells and prevents the development of lupuslike autoimmune disease. J. Exp. Med. 2008, 205:2295-2307.